|
| 36821462 | Reply: Misidentified Dopamine Agonists Undermine Investigation Into Aripiprazole Link With Impulse Control Disorders. | J Clin Psychopharmacol | 2023 |
| 37745065 | Implementation of pharmacogenetic testing in oncology: <i>DPYD</i>-guided dosing to prevent fluoropyrimidine toxicity in British Columbia. | Front Pharmacol | 2023 |
| 35748941 | Cisplatin-induced nephrotoxicity in childhood cancer: comparison between two countries. | Pediatr Nephrol | 2023 |
| 37208845 | Optimizing therapeutic decision-making for off-label medicines use: A scoping review and consensus recommendations for improving practice and research<sup/>. | Pharmacoepidemiol Drug Saf | 2023 |
| 37133221 | Which children are still dying from asthma? A 13 year review of pediatric asthma deaths in British Columbia, Canada. | Pediatr Pulmonol | 2023 |
| 37360870 | Benefits v. risks of COVID-19 vaccination: an examination of vaccination policy impact on the occurrence of myocarditis and pericarditis. | Lancet Reg Health West Pac | 2023 |
| 37397090 | <i>RBL2</i> Regulates Cardiac Sensitivity to Anthracycline Chemotherapy. | JACC CardioOncol | 2023 |
| 36917731 | Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children. | Ther Drug Monit | 2023 |
| 36582125 | Noninvasive testing for mycophenolate exposure in children with renal transplant using urinary metabolomics. | Pediatr Transplant | 2023 |
| 36803903 | Vaccinomics: A scoping review. | Vaccine | 2023 |
| 36728273 | Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced Cardiotoxicity. | Ther Drug Monit | 2023 |
| 34490624 | The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments. | Cancer | 2022 |
| 35680552 | Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services. | Clin Infect Dis | 2022 |
| 35803881 | Paediatric oral formulations: Why don't our kids have the medicines they need? | Br J Clin Pharmacol | 2022 |
| 35830229 | Pharmacogenetic testing in pediatric neurology: a pragmatic study evaluating clinician and patient perceptions. | Per Med | 2022 |
| 35757208 | Editorial: Real-World Evidence of Pediatric Exposure to Psychopharmacologic Medications. | Front Psychiatry | 2022 |
| 36143179 | A Systematic Review of Polygenic Models for Predicting Drug Outcomes. | J Pers Med | 2022 |
| 36331922 | All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicity. | PLoS One | 2022 |
| 36126025 | The Canadian Mother-Child Cohort Active Surveillance Initiative (CAMCCO): Comparisons between Quebec, Manitoba, Saskatchewan, and Alberta. | PLoS One | 2022 |
| 36053661 | Quantifying the intensity of adverse events with ibuprofen and oxycodone: an observational cohort study. | BMJ Paediatr Open | 2022 |
| 33900042 | Pharmacogenetic testing to guide therapeutic decision-making and improve outcomes for children undergoing anthracycline-based chemotherapy. | Basic Clin Pharmacol Toxicol | 2022 |
| 35153845 | Hydroxyzine Use in Preschool Children and Its Effect on Neurodevelopment: A Population-Based Longitudinal Study. | Front Psychiatry | 2022 |
| 35149390 | A pharmacogenomic investigation of the cardiac safety profile of ondansetron in children and pregnant women. | Biomed Pharmacother | 2022 |
| 35147047 | Pharmacogenomic study of anthracycline-induced cardiotoxicity in Mexican pediatric patients. | Pharmacogenomics | 2022 |
| 34907575 | Pharmacogenomic testing in paediatrics: Clinical implementation strategies. | Br J Clin Pharmacol | 2022 |
| 34874743 | Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity. | Circulation | 2022 |
| 35107877 | Patient-specific genetic factors predict treatment failure in sofosbuvir-treated patients with chronic hepatitis C. | Liver Int | 2022 |
| 32976737 | Pharmacogenomics in Pediatric Oncology: Mitigating Adverse Drug Reactions While Preserving Efficacy. | Annu Rev Pharmacol Toxicol | 2021 |
| 35368557 | Urine Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 to Detect Pediatric Cisplatin-Associated Acute Kidney Injury. | Kidney360 | 2021 |
| 33852809 | COVID-19 pathophysiology and pharmacology: what do we know and how did Canadians respond? A review of Health Canada authorized clinical vaccine and drug trials. | Can J Physiol Pharmacol | 2021 |
| 33794308 | Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis. | Crit Rev Oncol Hematol | 2021 |
| 33769074 | Integrating disease and drug-related phenotypes for improved identification of pharmacogenomic variants. | Pharmacogenomics | 2021 |
| 33715268 | Pharmacoepidemiology: A time for a new multidisciplinary approach to precision medicine. | Pharmacoepidemiol Drug Saf | 2021 |
| 33820548 | DRESS induced by amoxicillin-clavulanate in two pediatric patients confirmed by lymphocyte toxicity assay. | Allergy Asthma Clin Immunol | 2021 |
| 33581749 | Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study. | Lancet Child Adolesc Health | 2021 |
| 34763988 | Corrigendum to 'SJS/TEN 2019: From science to translation' [J. Dermatol. Sci. 98/1 (2020) 2-12]. | J Dermatol Sci | 2021 |
| 34499688 | An observational cohort study comparing ibuprofen and oxycodone in children with fractures. | PLoS One | 2021 |
| 34383016 | Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report. | JAMA Oncol | 2021 |
| 34820133 | A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol. | Can J Kidney Health Dis | 2021 |
| 34525346 | RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy. | Cell Stem Cell | 2021 |
| 34562771 | Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment. | Biomed Pharmacother | 2021 |
| 34834585 | Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study. | J Pers Med | 2021 |
| 34021165 | Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity. | NPJ Genom Med | 2021 |
| 34152932 | Vaccinomics: a cross-sectional survey of public values. | Hum Vaccin Immunother | 2021 |
| 33973801 | Deliberations about clinical pharmacogenetic testing in pediatric oncology. | Per Med | 2021 |
| 33137189 | Guillain-Barré Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence. | J Infect Dis | 2021 |
| 33006916 | Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings. | Annu Rev Pharmacol Toxicol | 2021 |
| 32510242 | An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects. | Expert Opin Drug Metab Toxicol | 2020 |
| 31937606 | Big Data in the Assessment of Pediatric Medication Safety. | Pediatrics | 2020 |
| 31673144 | CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis. | Pharmacogenomics J | 2020 |